Results 21 to 30 of about 48,282 (202)
A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options
Future Science OA, 2020 Carbapenems are a class of antimicrobial agents reserved for infections caused by multidrug-resistant microorganisms. The emergence of carbapenem resistance has become a serious public health threat.
Ann A Elshamy, Khaled M Aboshanab
doaj +1 more source
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022 Introduction: Interest in fosfomycin, an old antibiotic, has been reignited because of the use of its intravenous formulation (fosfomycin sodium) in resistant infections.
Yakup GEZER +4 more
doaj +1 more source
Management of carbapenem-resistant Enterobacteriaceae infections [PDF]
Clinical Microbiology and Infection, 2019 Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele +2 more
openaire +3 more sources
Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review
Revista da Sociedade Brasileira de Medicina Tropical, 2020 Consumption of carbapenem has increased due to extended-spectrum beta-lactamase-producing bacteria spreading. Ertapenem has been suggested as a not carbapenem-resistance inducer.
Tiago Zequinão +3 more
doaj +1 more source
PLoS ONE, 2023 BackgroundCarbapenem resistance is perceived as a clinical challenge in the management of debilitated and immunocompromised patients who eventually will die from underlying diseases.
Chiu-Hsia Su +3 more
doaj +1 more source
A systematic review: the current status of carbapenem resistance in East Africa
BMC Research Notes, 2018 Objective In this systematic review, we present the molecular epidemiology and knowledge gaps of the carbapenem resistance in East Africa as well as the future probable research interventions that can be used to address the emergence of carbapenem ...
Kenneth Ssekatawa +3 more
doaj +1 more source
Microbiology Spectrum, 2023 We report that carbapenem resistance developed in an extensively drug-resistant Salmonella enterica serovar Agona strain during antimicrobial therapy and in an AmpC β-lactamase-producing S. Infantis strain.
Ping-Chun Hsu +6 more
doaj +1 more source
Carbapenemase-producing Aeromonas species isolated from the urban-impacted Akaki river in Ethiopia
Journal of Water and Health, 2022 Carbapenemase-producing Aeromonas species are an emerging health threat. This study aimed to determine carbapenemase-mediated resistance among Aeromonas isolates from the Akaki river, Ethiopia during the dry and wet seasons in 2019–2020.
Berhanu Yitayew +6 more
doaj +1 more source
Resistance Pattern of Carbapenem on Enterobacteriaceae
Journal of Nepal Medical Association, 2018 Introduction: Gram negative bacilli are the important causes of common clinical infections. Carbapenem resistant Enterobacteriaceae are considered as important public health threat and is classified as urgent by the Centers of Disease Control and Prevention because of their progressive geographic dissemination and limited therapeutic alternatives. This
Khilasa Pokharel +4 more
openaire +4 more sources
International Journal of Infectious Diseases, 2017 Objective: The impact of pediatric antimicrobial stewardship programs (ASP) on antimicrobial resistance (AMR) remains largely unknown. This study aimed to evaluate the AMR for carbapenem of Gram-negative bacilli (GNB) and carbapenem use with infectious ...
Yuho Horikoshi +9 more
doaj +1 more source